These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36962104)

  • 41. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
    Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
    Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
    [No Abstract]   [Full Text] [Related]  

  • 43. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.
    Hatherill M; Geldenhuys H; Pienaar B; Suliman S; Chheng P; Debanne SM; Hoft DF; Boom WH; Hanekom WA; Johnson JL
    Vaccine; 2014 Jun; 32(31):3982-8. PubMed ID: 24814553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epitope promiscuity and population coverage of Mycobacterium tuberculosis protein antigens in current subunit vaccines under development.
    Ong E; He Y; Yang Z
    Infect Genet Evol; 2020 Jun; 80():104186. PubMed ID: 31923726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A century of attempts to develop an effective tuberculosis vaccine: Why they failed?
    Soleimanpour S; Yaghoubi A; Sadat Seddighinia F; Rezaee SAR
    Int Immunopharmacol; 2022 Aug; 109():108791. PubMed ID: 35487086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques.
    Darrah PA; DiFazio RM; Maiello P; Gideon HP; Myers AJ; Rodgers MA; Hackney JA; Lindenstrom T; Evans T; Scanga CA; Prikhodko V; Andersen P; Lin PL; Laddy D; Roederer M; Seder RA; Flynn JL
    NPJ Vaccines; 2019; 4():21. PubMed ID: 31149352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The TB vaccine development pathway - An innovative approach to accelerating global TB vaccine development.
    Roordink D; Williams A; Fritzell B; Laddy DJ; Gerdil E; Graffin AM; Tait D; van der Pol L; van den Brink I; Holleman M; Thole J; Voss G; Lempicki M; Thiry G
    Tuberculosis (Edinb); 2021 Jan; 126():102040. PubMed ID: 33310626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acceptability of decentralizing childhood tuberculosis diagnosis in low-income countries with high tuberculosis incidence: Experiences and perceptions from health care workers in Sub-Saharan Africa and South-East Asia.
    Joshi B; De Lima YV; Massom DM; Kaing S; Banga MF; Kamara ET; Sesay S; Borand L; Taguebue JV; Moh R; Khosa C; Breton G; Mwanga-Amumpaire J; Bonnet M; Wobudeya E; Marcy O; Orne-Gliemann J;
    PLOS Glob Public Health; 2023; 3(10):e0001525. PubMed ID: 37819919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.
    Idoko OT; Owolabi OA; Owiafe PK; Moris P; Odutola A; Bollaerts A; Ogundare E; Jongert E; Demoitié MA; Ofori-Anyinam O; Ota MO
    Tuberculosis (Edinb); 2014 Dec; 94(6):564-78. PubMed ID: 25305000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tuberculosis vaccines: Opportunities and challenges.
    Zhu B; Dockrell HM; Ottenhoff THM; Evans TG; Zhang Y
    Respirology; 2018 Apr; 23(4):359-368. PubMed ID: 29341430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
    Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NATCON 2022 Panel discussion: "TB vaccination - Going Forward".
    Banurekha VV; Padmapriyadarsini C; Bhargava S; Sachdeva K
    Indian J Tuberc; 2023 Jul; 70(3):366-369. PubMed ID: 37562914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A century of BCG: Impact on tuberculosis control and beyond.
    Ahmed A; Rakshit S; Adiga V; Dias M; Dwarkanath P; D'Souza G; Vyakarnam A
    Immunol Rev; 2021 May; 301(1):98-121. PubMed ID: 33955564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "I got tested at home, the help came to me": acceptability and feasibility of home-based TB testing of household contacts using portable molecular diagnostics in South Africa.
    Medina-Marino A; de Vos L; Bezuidenhout D; Denkinger CM; Schumacher SG; Shin SS; Stevens W; Theron G; van der Walt M; Daniels J
    Trop Med Int Health; 2021 Mar; 26(3):343-354. PubMed ID: 33289194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.